HIV/AIDS Surveillance in Europe 2011
With no clear indication of a decline in the number of cases being diagnosed each year, HIV continues to be a major public health concern for Europe. In 2011, more than 28 000 new cases were diagnosed in European Union and European Economic Area Member States; a rate of 5.7 cases in every 100 000 people.
This report, prepared jointly with the WHO Regional Office for Europe, presents data on HIV and AIDS for the whole European Region, including the EU and EEA countries. Analyses are provided for the EU and EEA region, and also by geographical area of the WHO European Region.
HIV/AIDS Surveillance in Europe 2011 - slideshow presentation
Brucellosis – Annual Epidemiological Report for 2017
19 Jun 2019 - In 2017, 381 confirmed brucellosis cases were reported in the EU/EEA. The notification rate in the EU/EEA was 0.09 cases per 100 000 population. The highest rates were reported in southern EU Member States (Greece, Italy and Portugal). The highest rate was observed in 25–44-year-old males (0.16 per 100 000). The notification rate was stable from 2013–2017 in the EU/EEA.
Diphtheria - Annual Epidemiological Report for 2017
19 Jun 2019 - For 2017, 39 cases of diphtheria due to toxigenic Corynebacterium diphtheriae or C. ulcerans were reported to ECDC. The highest proportion of C. ulcerans cases was among adults 45 years of age and above, whereas C. diphtheriae cases were more common in younger age groups. Among C. diphtheriae cases, 50% were reported as imported. High vaccination coverage is crucial to prevent diphtheria.
Congenital toxoplasmosis – Annual Epidemiological Report for 2016
19 Jun 2019 - In 2016, 242 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 81% of all confirmed cases due to the active screening of pregnant women. The notification rate was 6.7 cases per 100 000 live births. No seasonal pattern was observed for the disease.